{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:08:26Z","timestamp":1761988106930},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.cyto.2006.06.009","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T12:49:18Z","timestamp":1157028558000},"page":"1-5","source":"Crossref","is-referenced-by-count":24,"title":["Cytokine gene polymorphisms can alter the effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) immunotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Bilkay","family":"Basturk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismet","family":"Yavascaoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbaros","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcher","family":"G\u00f6ral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2006.06.009_bib1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2006.06.009_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","article-title":"Cancer statistics","volume":"48","author":"Parker","year":"1998","journal-title":"CA J Clin Cancer"},{"key":"10.1016\/j.cyto.2006.06.009_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1097-0142(197709)40:3<1246::AID-CNCR2820400340>3.0.CO;2-5","article-title":"The epidemiology of bladder cancer: a second look","volume":"40","author":"Wynder","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2006.06.009_bib4","series-title":"Cellular and molecular immunology","author":"Abbas","year":"2000"},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2006.06.009_bib5","first-page":"135","article-title":"Human cytokine gene nucleotide sequence alignments","volume":"26","author":"Bidwell","year":"1998","journal-title":"Eur J Immunogenet"},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2006.06.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2370.1999.00122.x","article-title":"In vitro production of IFN-\u03b3 correlates with CA repeat polymorphism in IFN-\u03b3 gene","volume":"26","author":"Pravica","year":"1999","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.cyto.2006.06.009_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the IL10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.cyto.2006.06.009_bib8","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"Novel polymorphisms in the interleukin-6 gene: their effect on IL-6 transcription, plasma IL-6 levels and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2006.06.009_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The \u2212308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cyto.2006.06.009_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/jlts.2002.50014","article-title":"Are cytokine gene polymorphisms related to in vitro cytokine production profiles","volume":"9","author":"Warl\u00e9","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cyto.2006.06.009_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cyto.2004.10.016","article-title":"Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma","volume":"30","author":"Basturk","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2006.06.009_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1572-0241.2003.07179.x","article-title":"Cytokine gene polymorphisms in patients infected with hepatitis B virus","volume":"98","author":"Ben-Ari","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cyto.2006.06.009_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0094-0143(21)00140-3","article-title":"Management of carcinoma-in-situ of the bladder: the case for surgical management","volume":"7","author":"Utz","year":"1980","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.cyto.2006.06.009_bib14","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(01)65396-5","article-title":"A combined analysis of European organization for research and treatment of cancer, and medical research council randomized clinical trails for the prophylactic treatment of stage TaT1 bladder cancer","volume":"156","author":"Parwiski","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.cyto.2006.06.009_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(01)64015-1","article-title":"New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma","volume":"159","author":"Patel","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.cyto.2006.06.009_bib16","first-page":"35","article-title":"History of BCG and substrains","volume":"310","author":"Crispen","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.cyto.2006.06.009_bib17","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0022-5347(05)64361-3","article-title":"Urinary interleukin-8 predicts the response of standard and low dose intravesical Bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer","volume":"168","author":"Kumar","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.cyto.2006.06.009_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1464-410X.2001.02394.x","article-title":"Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment","volume":"88","author":"Saint","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.cyto.2006.06.009_bib19","first-page":"11","article-title":"Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview","volume":"310","author":"Van Der Meijden","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.cyto.2006.06.009_bib20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1996.14.6.1778","article-title":"Prediction of responses to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression","volume":"14","author":"Kaempfer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cyto.2006.06.009_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.1398","article-title":"Role of tissue stroma in cancer cell invasion","volume":"200","author":"De Wever","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.cyto.2006.06.009_bib22","first-page":"5329","article-title":"Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas","volume":"58","author":"Goggins","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2006.06.009_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000065295","article-title":"Regulation of inducible class II MHC, costimulatory molecules, and cytokine expression in TGF-beta1 knockout renal epithelial cells: effect of exogenous TGF-beta1","volume":"10","author":"Banu","year":"2002","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.cyto.2006.06.009_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1078\/0171-9335-00265","article-title":"TGF beta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line","volume":"81","author":"Yi","year":"2002","journal-title":"Eur J Cell Biol"},{"issue":"2","key":"10.1016\/j.cyto.2006.06.009_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/stem.150144","article-title":"Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow","volume":"15","author":"Yamaguchi","year":"1997","journal-title":"Stem Cells"},{"key":"10.1016\/j.cyto.2006.06.009_bib26","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/IAI.71.5.2933-2937.2003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG producing the cholera toxin B subunit","volume":"71","author":"Biet","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2006.06.009_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/CDLI.5.4.588-591.1998","article-title":"Inhibition of Mycobacterium bovis BCG-induced tumor necrosis factor alpha secretion in human cells by transforming growth factor beta","volume":"5","author":"Mendez-Samperio","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cyto.2006.06.009_bib28","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.4049\/jimmunol.166.11.6728","article-title":"TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways","volume":"166","author":"Bekker","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2006.06.009_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.coi.2004.01.010","article-title":"Immunoregulatory T cells in tumor immunity","volume":"16","author":"Terabe","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cyto.2006.06.009_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2006.06.009_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and Interleukin-10 receptors","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2006.06.009_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","article-title":"The role IFN-\u03b3 in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2006.06.009_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00571848","article-title":"On the mode of action of intravesical bacillus Calmette-Guerin: in vitro characterization of BCG-activated killer cells","volume":"22","author":"Bohle","year":"1994","journal-title":"Urol Res"},{"key":"10.1016\/j.cyto.2006.06.009_bib34","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0022-5347(17)35941-4","article-title":"Dissecting the immunobiological effects of bacillus Calmette-Guerin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon","volume":"150","author":"Bohle","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.cyto.2006.06.009_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.gene.6363750","article-title":"Structural characterisation of the distal 5\u2032 flanking region of the human interleukin-10 gene","volume":"2","author":"Kube","year":"2001","journal-title":"Genes Immunity"},{"key":"10.1016\/j.cyto.2006.06.009_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2249.2003.02071.x","article-title":"Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guerin (BCG) mediated antitumour activity","volume":"2","author":"Nadler","year":"2003","journal-title":"Clin Exp Immunol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466606001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466606001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T01:40:30Z","timestamp":1627782030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466606001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1043466606001931"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2006.06.009","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}